MedTrace Logo

Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

NCT02402023 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-03-09

No results posted yet for this study

Summary

The purpose of this clinical trial is to determine the feasibility and efficacy of an intervention designed to increase rates of tobacco abstinence for cancer patients before their cancer surgery.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Contingency Management (CM)

CM is standard care plus monetary payment delivered contingent on abstinence.

BEHAVIORAL

Standard of Care (SC)

Standard of care consists of smoking cessation counseling sessions and nicotine patches.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Benjamin Toll, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02402023 on ClinicalTrials.gov